SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Education and awareness related to Atopic dermatitis awareness
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Economics/Economic Development ECN
General issues related to the importance of foreign direct investment in the U.S.
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc. invests in its business in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Trade (domestic/foreign) TRD
General issues related to the Trans-Pacific Partnership (TPP) negotiations.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACOB ANDREW HARTSFIELD New | — |
| PATRICK MAYES MCLAIN | — |
Taxation/Internal Revenue Code TAX
General issues related to corporate tax reform, including the deduction of interest,general issues related to the 40% excise tax on employer-sponsored health care; and all provisions of HR1270 and S709 "Restoring Access to Medication Act of 2015".
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
International intellectual property issues and provisions related to Canada Promise Doctrine.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACOB ANDREW HARTSFIELD New | — |
| PATRICK MAYES MCLAIN | — |
Health Issues HCR
Education and awareness of the 2015-2016 influenza season; all issues related to the Innovations for Healthier Americans Initiative; general issues related to the value of prescription medicines; general issues related to the importation of prescription drugs including all progvisions of S122 "Safe and Affordable Drugs from Canada Act of 2015"; issues related to the Over The Counter (OTC) Monograph reform; and general issues related to access to adult vaccines; general issues related to Zika Outbreaks; general issues related to Priority Review Vouchers; general issues related to Tropical Disease PRV Program; education and awareness of pandemic and biodefense funding; general issues related to the value of prescription medicines; issues related to S2742 "Promoting Biomedical Research and Public Health Patient Act" provision Section 6 National Vaccine Injury; issues related to S2512/H.R. "Adding Zika Virus to the FDA Priority Review Voucher Program Act"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Medicare/Medicaid MMM
General issues related to the Medicare Part D Program; coverage and reimbursement for the Medicare Part D prescription drug benefit and all provisions of S31 "Medicare Prescription Drug Price Negotiation Act"; general issues related to Medicare Part B Reimbursement; general issues related to Medicare Chronic Care Reform
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Animals ANI
General issues related to animal drug compounding; general issues related to the veterinary biologics National Environmental Policy Act (NEPA) exclusion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Pharmacy PHA
General issues related to the 340B Federal Drug Pricing Progranm
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Torts TOR
General issues related to reforms to the Vaccine Injury Compensation Program (VICP).
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SANOFI PASTEUR | Swiftewater, PA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.